Abviva, Inc. · Los Angeles, CA United States ·(OTC: ABVV)
Company Description
Phone: 310-443-4102
Fax: 310-443-4103
View Abviva, Inc. Locations On A US Map
This link will open in a new window
Abviva aims to bring better diagnostics to the fight against breast cancer. The drug developer (formerly known as Genesis Bioventures) is working on proteomics-based cancer diagnostics and therapeutics. Its wholly owned subsidiary Biomedical Diagnostics has developed a blood test, called the Mammastatin Serum Assay, which assesses a person's risk for developing breast cancer. Abviva also has a significant stake in Prion Developmental Laboratories, a developer of diagnostic tools for Mad Cow Disease and a similar neurodegenerative disorder that affects deer and elk called Chronic Wasting Disease. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key Abviva, Inc. Financials
| Company Type | Public - OTC: ABVV Headquarters |
| Fiscal Year-End | December |
| 2000 Sales (mil.) | $0.0 |
| 2007 Employees | 5 |
Abviva, Inc. Executives
3 executives listed for Abviva, Inc.'s Los Angeles, CA location.
| Title | Name & Bio | Contact |
| President, CEO, and Director | Douglas Lane | Network |
| Secretary and Director | Jeffrey Conrad | Network |
| Director | Barrett Evans | Network |
Competition
Competitive Landscape for Abviva, Inc.
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top Abviva, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
